# Potential Role of Gum Arabic as Immunomodulatory Agent Among COVID 19 Patients

> **NCT04381871** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Al-Neelain University** · enrollment: 110 (estimated)

## Conditions studied

- COVID 19

## Interventions

- **DIETARY_SUPPLEMENT:** Acacia Senegal
- **DIETARY_SUPPLEMENT:** Pectin

## Key facts

- **NCT ID:** NCT04381871
- **Lead sponsor:** Al-Neelain University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-06-01
- **Primary completion:** 2020-08-01
- **Final completion:** 2020-09-01
- **Target enrollment:** 110 (ESTIMATED)
- **Last updated:** 2020-05-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04381871

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04381871, "Potential Role of Gum Arabic as Immunomodulatory Agent Among COVID 19 Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04381871. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*